Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › BLT2-mediated disease, BLT2 binding agent and the compound

BLT2-mediated disease, BLT2 binding agent and the compound

US Patent 8673889 · Granted Mar 18, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Preventive or therapeutic agent for age-related macular degeneration2020
Compound capable of binding S1P receptor and pharmaceutical use thereof2014
Pharmaceutical composition for treatment of disease due to vascular constriction2014
Compound having S1P receptor binding potency and use thereof2014
Aminocarboxylic acid derivative and medicinal use thereof2013
LPA receptor antagonist2012
Benzofuran compound and pharmaceutical composition containing the same2011
Compound having S1P receptor binding potency and use thereof2011
Promoter of novel calcium-independent phospholipase A22011
Aminocarboxylic acid derivative and medicinal use thereof2011
Compounds having lysophosphatidic acid receptor antagonism and uses thereof2011
Compound capable of binding S1P receptor and pharmaceutical use thereof2010